Pediatric hormonal disturbances after hematopoietic stem cell transplantation. Issue 1 (January 2013)

• Record Type: Journal Article
• Authors: Siklar, Zeynep; Berberoglu, Merih
• Is Part Of: Expert review of endocrinology & metabolism. Volume 8:Issue 1(2013)
• Page Start: 81
• Page End: 90
• Publication Date: 2013-01
• Subjects: child -- hematopoietic stem cell transplantation -- hormone disturbances -- late adverse effects -- whole-body irradiation; Endocrinology -- Periodicals; Metabolism -- Periodicals; 616.4
• DOI: 10.1586/eem.12.71
• Languages: English
• ISSNs: 1744-6651

Abstract

Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for various malignant and nonmalignant diseases. Improvement of HSCT in children has resulted in many long-term survivors with substantial long-term morbidities. Endocrine complications are most frequently observed as late effects in HSCT recipients. Growth failure, pubertal disorders, thyroid dysfunctions, obesity, metabolic syndrome and bone loss are usually encountered after HSCT in children, while infertility is an important problem in adulthood. Patient age at HSCT, characteristics of primary diseases, intervention duration, preparative conditioning regimens, dose of irradiation and specificity of chemotherapeutic agents affect the prevalence of endocrine late effects. Awareness of endocrine late effects of HSCT and close follow-up of patients would help to increase the quality of health of patients.